Effect of genetic modifiers on cerebral lesions in Fabry disease.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15985593.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fabry disease is associated with increased risk of premature stroke and presumptive ischemic cerebral lesions. In 57 consecutive patients, 35% of whom had lesions on brain MRI, the authors found that genotypes of polymorphisms G-174C of interleukin-6, G894T of endothelial nitric oxide synthase, factor V G1691A mutation, and the A-13G and G79A of protein Z were all significantly associated with cerebral lesions. These findings suggest that these proteins modulate Fabry cerebral vasculopathy.
Medical subject headings
- Brain Ischemia
- Cerebral Arteries
- Cerebral Infarction
- Fabry Disease
- Genetic Predisposition to Disease
- Mutation